EcoDrugPlus

Ensembl ID : ENSMLUG00000023988
Gene Symbol: -
Cross references: -
234 Possible Orthologues:

Ensembl ID : ENSMLUG00000023508
Gene Symbol: -
Cross references: -
203 Possible Orthologues:

Ensembl ID : ENSMLUG00000023365
Gene Symbol: -
Cross references: -
351 Possible Orthologues:

Ensembl ID : ENSMLUG00000022472
Gene Symbol: -
Cross references: -
297 Possible Orthologues:

Ensembl ID : ENSMLUG00000012536
Gene Symbol: -
Cross references: -
274 Possible Orthologues:

Ensembl ID : ENSMLUG00000017116
Gene Symbol: -
Cross references: -
226 Possible Orthologues:

Ensembl ID : ENSMLUG00000016721
Gene Symbol: -
Cross references: -
215 Possible Orthologues:

Ensembl ID : ENSMLUG00000017489
Gene Symbol: -
Cross references: -
453 Possible Orthologues:

Ensembl ID : ENSMLUG00000028079
Gene Symbol: -
Cross references: -
188 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).